⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

September 9, 2024Frontiers in NeuroscienceOpen Access

Observations on the efficacy of edaravone dexborneol in preventing post-stroke depression and its inflammatory mechanism: a prospective, randomized, control trial

Mingyuan Xu Lan Li Bu Xu S. Yuan Qin Zheng Wenjun Sun

View Full Paper

Ask AI

Bookmark

Share

Abstract

This study aimed to observe the effect of edaravone dexborneol (EDB) on the incidence of early post-stroke depression (PSD) and explore its inflammatory mechanisms.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Xu et al. (2024) studied this question.

synapsesocial.com/papers/68e58feab6db64358752b417 https://doi.org/10.3389/fnins.2024.1451060

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Clinical efficacy of edaravone dexborneol in the treatment of acute ischemic stroke: meta-analysis2025 · 4 citations
2Effects of edaravone dexborneol on functional outcome and inflammatory response in patients with acute ischemic stroke2024 · 23 citations
3Evaluating the Efficacy and Safety of Edaravone-Dexborneol in Acute Ischemic Stroke: An Updated Systematic Review and Meta-Analysis of 7,846 Chinese Patients.Human Clinical Trial · 2026 · 5 citations
4ABSTRACT NUMBER: ESOC2026A1708 EDARAVONE DEXBORNEOL AND NINETY DAY FUNCTIONAL RECOVERY IN ACUTE ISCHEMIC STROKE: A SYSTEMATIC REVIEW AND META ANALYSISMeta-Analysis · 2026
5ABSTRACT NUMBER: ESOC2026A1065 ACUTE ISCHEMIC STROKE OUTCOMES WITH EDARAVONE–DEXBORNEOL: A META-ANALYTIC STUDYRCT · 2026